Profitable Pharmaceuticals Company Investment Opportunity in Nonthaburi, Thailand
Established | 10-20 year(s) |
Employees | 10 - 50 |
Legal Entity | Private Limited Company |
Reported Sales | USD 426 thousand |
Run Rate Sales | USD 490 thousand |
EBITDA Margin | 30 % |
Industries | Alternative Medicine + 1 more |
Locations | Nonthaburi |
Local Time | 7:38 AM Asia / Vientiane |
Listed By | Business Owner / Director |
Status | Active |
We have been selling and exporting to many countries in Asia with our own patents and trade marks. The sales growing well each year so, when the sales increase the investment for funding support are needed.
The reason for the loan is to support cash flow and stock inventory.
Major products such as silicone gel for scar reduction, Asian formula, and silicone gel sheet for scars.
Kelosil silicone gel plus CBD, we are the only one who can combine CBD (cannabidiol into silicone gel with transparent texture, which will a new evolution of silicone gel for wound healing and scar reductuion products.
The new invention for cannabis (CBD) product development, we are brand owner of CBD products such as CBD cream, CBD drinks,
Estimate Sales (year sales)
2022 = 44,000 USD.
2023 = USD 55,000.
2024 = USD 100,000.
2025 = USD 150,000.
2026 = USD 300,000.
2. Silicone gel and silicone sheet for scar patients. We have patents for both the silicone gel and silicone gel sheets.
-
Earlier than 15 daysBusiness Director, Technology, Singapore, Individual Investor / Buyer connected with the Business
-
Earlier than 15 daysProprietor, Media, Ko Samui, Individual Investor / Buyer connected with the Business
-
Earlier than 15 daysDirector, Manufacturing, Bangkok, Individual Investor / Buyer connected with the Business